Literature DB >> 26019342

Selective inhibition of KCC2 leads to hyperexcitability and epileptiform discharges in hippocampal slices and in vivo.

Sudhir Sivakumaran1, Ross A Cardarelli2, Jamie Maguire3, Matt R Kelley3, Liliya Silayeva2, Danielle H Morrow3, Jayanta Mukherjee2, Yvonne E Moore3, Robert J Mather4, Mark E Duggan4, Nicholas J Brandon4, John Dunlop4, Stephen Zicha4, Stephen J Moss5, Tarek Z Deeb6.   

Abstract

GABA(A) receptors form Cl(-) permeable channels that mediate the majority of fast synaptic inhibition in the brain. The K(+)/Cl(-) cotransporter KCC2 is the main mechanism by which neurons establish low intracellular Cl(-) levels, which is thought to enable GABAergic inhibitory control of neuronal activity. However, the widely used KCC2 inhibitor furosemide is nonselective with antiseizure efficacy in slices and in vivo, leading to a conflicting scheme of how KCC2 influences GABAergic control of neuronal synchronization. Here we used the selective KCC2 inhibitor VU0463271 [N-cyclopropyl-N-(4-methyl-2-thiazolyl)-2-[(6-phenyl-3-pyridazinyl)thio]acetamide] to investigate the influence of KCC2 function. Application of VU0463271 caused a reversible depolarizing shift in E(GABA) values and increased spiking of cultured hippocampal neurons. Application of VU0463271 to mouse hippocampal slices under low-Mg(2+) conditions induced unremitting recurrent epileptiform discharges. Finally, microinfusion of VU0463271 alone directly into the mouse dorsal hippocampus rapidly caused epileptiform discharges. Our findings indicated that KCC2 function was a critical inhibitory factor ex vivo and in vivo.
Copyright © 2015 the authors 0270-6474/15/358291-06$15.00/0.

Entities:  

Keywords:  GABAA; KCC2; VU0463271; chloride; seizures; slices

Mesh:

Substances:

Year:  2015        PMID: 26019342      PMCID: PMC4444547          DOI: 10.1523/JNEUROSCI.5205-14.2015

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  39 in total

1.  Guide to Receptors and Channels (GRAC), 5th edition.

Authors:  Stephen P H Alexander; Alistair Mathie; John A Peters
Journal:  Br J Pharmacol       Date:  2011-11       Impact factor: 8.739

2.  Impact of inhibitory constraint of interneurons on neuronal excitability.

Authors:  Vallent Lee; Jamie Maguire
Journal:  J Neurophysiol       Date:  2013-09-11       Impact factor: 2.714

3.  Furosemide and mannitol suppression of epileptic activity in the human brain.

Authors:  Michael M Haglund; Daryl W Hochman
Journal:  J Neurophysiol       Date:  2005-02-23       Impact factor: 2.714

4.  Anticonvulsant actions of furosemide in vitro.

Authors:  K U Gutschmidt; K Stenkamp; K Buchheim; U Heinemann; H Meierkord
Journal:  Neuroscience       Date:  1999       Impact factor: 3.590

Review 5.  Translocator protein (18 kDa) (TSPO) as a therapeutic target for neurological and psychiatric disorders.

Authors:  Rainer Rupprecht; Vassilios Papadopoulos; Gerhard Rammes; Thomas C Baghai; Jinjiang Fan; Nagaraju Akula; Ghislaine Groyer; David Adams; Michael Schumacher
Journal:  Nat Rev Drug Discov       Date:  2010-12       Impact factor: 84.694

6.  Dissociation of synchronization and excitability in furosemide blockade of epileptiform activity.

Authors:  D W Hochman; S C Baraban; J W Owens; P A Schwartzkroin
Journal:  Science       Date:  1995-10-06       Impact factor: 47.728

Review 7.  The extracellular space and epileptic activity in the adult brain: explaining the antiepileptic effects of furosemide and bumetanide.

Authors:  Daryl W Hochman
Journal:  Epilepsia       Date:  2012-06       Impact factor: 5.864

8.  NMDA receptor activity downregulates KCC2 resulting in depolarizing GABAA receptor-mediated currents.

Authors:  Henry H C Lee; Tarek Z Deeb; Joshua A Walker; Paul A Davies; Stephen J Moss
Journal:  Nat Neurosci       Date:  2011-05-01       Impact factor: 24.884

9.  Improved method for efficient imaging of intracellular Cl(-) with Cl-Sensor using conventional fluorescence setup.

Authors:  Perrine Friedel; Piotr Bregestovski; Igor Medina
Journal:  Front Mol Neurosci       Date:  2013-04-10       Impact factor: 5.639

10.  Kainate receptors coexist in a functional complex with KCC2 and regulate chloride homeostasis in hippocampal neurons.

Authors:  Vivek Mahadevan; Jessica C Pressey; Brooke A Acton; Pavel Uvarov; Michelle Y Huang; Jonah Chevrier; Andrew Puchalski; Caiwei M Li; Evgueni A Ivakine; Matti S Airaksinen; Eric Delpire; Roderick R McInnes; Melanie A Woodin
Journal:  Cell Rep       Date:  2014-06-05       Impact factor: 9.423

View more
  38 in total

1.  Compromising KCC2 transporter activity enhances the development of continuous seizure activity.

Authors:  Matthew R Kelley; Tarek Z Deeb; Nicholas J Brandon; John Dunlop; Paul A Davies; Stephen J Moss
Journal:  Neuropharmacology       Date:  2016-04-21       Impact factor: 5.250

2.  Tenuous Inhibitory GABAergic Signaling in the Reticular Thalamus.

Authors:  Peter M Klein; Adam C Lu; Megan E Harper; Hannah M McKown; Jessica D Morgan; Mark P Beenhakker
Journal:  J Neurosci       Date:  2017-12-22       Impact factor: 6.167

Review 3.  Hippocampal GABAergic Inhibitory Interneurons.

Authors:  Kenneth A Pelkey; Ramesh Chittajallu; Michael T Craig; Ludovic Tricoire; Jason C Wester; Chris J McBain
Journal:  Physiol Rev       Date:  2017-10-01       Impact factor: 37.312

4.  Imaging and serum biomarkers reflecting the functional efficacy of extended erythropoietin treatment in rats following infantile traumatic brain injury.

Authors:  Shenandoah Robinson; Jesse L Winer; Justin Berkner; Lindsay A S Chan; Jesse L Denson; Jessie R Maxwell; Yirong Yang; Laurel O Sillerud; Robert C Tasker; William P Meehan; Rebekah Mannix; Lauren L Jantzie
Journal:  J Neurosurg Pediatr       Date:  2016-02-19       Impact factor: 2.375

5.  N-Ethylmaleimide increases KCC2 cotransporter activity by modulating transporter phosphorylation.

Authors:  Leslie C Conway; Ross A Cardarelli; Yvonne E Moore; Karen Jones; Lisa J McWilliams; David J Baker; Matthew P Burnham; Roland W Bürli; Qi Wang; Nicholas J Brandon; Stephen J Moss; Tarek Z Deeb
Journal:  J Biol Chem       Date:  2017-11-01       Impact factor: 5.157

6.  The small molecule CLP257 does not modify activity of the K+-Cl- co-transporter KCC2 but does potentiate GABAA receptor activity.

Authors:  Ross A Cardarelli; Karen Jones; Lucie I Pisella; Heike J Wobst; Lisa J McWilliams; Paul M Sharpe; Matthew P Burnham; David J Baker; Ilona Chudotvorova; Justine Guyot; Liliya Silayeva; Danielle H Morrow; Niek Dekker; Stephen Zicha; Paul A Davies; Jörg Holenz; Mark E Duggan; John Dunlop; Robert J Mather; Qi Wang; Igor Medina; Nicholas J Brandon; Tarek Z Deeb; Stephen J Moss
Journal:  Nat Med       Date:  2017-12-07       Impact factor: 53.440

7.  The role of KCC2 in hyperexcitability of the neonatal brain.

Authors:  Yogendra H Raol; Srdjan M Joksimovic; Dayalan Sampath; Brock A Matter; Philip M Lam; Uday B Kompella; Slobodan M Todorovic; Marco I González
Journal:  Neurosci Lett       Date:  2020-08-26       Impact factor: 3.046

Review 8.  Status Epilepticus.

Authors:  Syndi Seinfeld; Howard P Goodkin; Shlomo Shinnar
Journal:  Cold Spring Harb Perspect Med       Date:  2016-03-01       Impact factor: 6.915

9.  Estradiol modulates the efficacy of synaptic inhibition by decreasing the dwell time of GABAA receptors at inhibitory synapses.

Authors:  Jayanta Mukherjee; Ross A Cardarelli; Yasmine Cantaut-Belarif; Tarek Z Deeb; Deepak P Srivastava; Shiva K Tyagarajan; Menelas N Pangalos; Antoine Triller; Jamie Maguire; Nicholas J Brandon; Stephen J Moss
Journal:  Proc Natl Acad Sci U S A       Date:  2017-10-16       Impact factor: 11.205

10.  The effects of chloride dynamics on substantia nigra pars reticulata responses to pallidal and striatal inputs.

Authors:  Ryan S Phillips; Ian Rosner; Aryn H Gittis; Jonathan E Rubin
Journal:  Elife       Date:  2020-09-07       Impact factor: 8.140

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.